|
⚲
|
| Keyboard |
| HBM BioCapital II LP
✚
|
|
|---|---|
| CIK # | 0001721496 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001721496] | |
| 4 | [0001721496] | |
| SC 13G | [0001721496] |
| Form 13D/13G Filer | Form 13D/13G Subject | Filed |
|---|---|---|
| HBM Biocapital II LP | Allena Pharmaceuticals Inc | [2017-11-16] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Allena Pharmaceuticals Inc | |
| HBM BioCapital II LP |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Allena Pharmaceuticals Inc ALNA
Common Stock
|
2017-11-06 | Conversion | 140,841 | ||
|
Allena Pharmaceuticals Inc ALNA
Common Stock
|
2017-11-06 | Buy | 71,428 | $14.00 | 999,992 |
|
Allena Pharmaceuticals Inc ALNA
Common Stock
|
2017-11-06 | Conversion | 1,426,061 | ||
|
Allena Pharmaceuticals Inc ALNA
Series B Preferred Stock · derivative
|
2017-11-06 | Conversion | 5,952,380 | ||
|
Allena Pharmaceuticals Inc ALNA
Series C Preferred Stock · derivative
|
2017-11-06 | Conversion | 587,872 |